MindMed’s Phase 2 LSD Trial Treating Anxiety Was a Success
Researchers at PSYCH Symposium reveal promising results from double-blind, placebo-controlled study with 46 patients.
Psych Symposium
Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors
Psychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.
End of content
End of content